Denham refers new round of cancer drugs to NICE

The National Institute for Clinical Excellence is to rule on whether a range of anti-cancer drugs should be available on the NHS. Health minister John Denham has referred a series of treatments to NICE, in a two-year programme. The list covers therapies for lung, colorectal, blood, breast, ovarian, brain and ...

You need to be signed in to read more


Subscribe for unlimited access

With a HSJ subscription you’ll unlock:

  • All of and our HSJ mobile app
  • News and insight on all areas of public funded healthcare
  • Expert commentary, insight and analysis from industry leaders
  • 9 weekly ‘Expert Briefing’ insight emails covering a variety of specialist topics

Sign into your account here